OBJECTIVES: To analyze the distant metastasis possibility based on computed tomography (CT) radiomic features in patients with lung cancer. METHODS: This was a retrospective analysis of 348 patients with lung cancer enrolled between 2014 and February 2015. A feature set containing clinical features and 485 radiomic features was extracted from the pretherapy CT images. Feature selection via concave minimization (FSV) was used to select effective features. A support vector machine (SVM) was used to evaluate the predictive ability of each feature. RESULTS: Four radiomic features and three clinical features were obtained by FSV feature selection. Classification accuracy by the proposed SVM with SGD method was 71.02%, and the area under the curv...
Background and purpose: Radiomics provides opportunities to quantify the tumor phenotype non-invasiv...
This paper concerns the development/analysis of the IQ-OTH/NCCD lung cancer dataset. This CT-scan da...
Stereotactic ablative radiotherapy (SABR) is the standard treatment recommendation for Stage I non-s...
PURPOSE:Radiomics provides quantitative tissue heterogeneity profiling and is an exciting approach t...
BACKGROUND: Lung cancer is one of the most common forms of cancer resulting in over a million deaths...
Lung cancer is one of the most common forms of cancer resulting in over a million deaths per year wo...
[[abstract]]Lung cancer is one of the major diseases which causes death in developed as well as deve...
BACKGROUND: Radiomics can quantify tumor phenotypic characteristics non-invasively by applying featu...
Lung cancer can be classified into two main categories: small cell lung cancer (SCLC) and non-small ...
Lung cancer is the leading cause of cancer-related death in the United States and worldwide. Early ...
Purpose: A new set of quantitative features that capture intensity changes in PET/CT images over tim...
The work aimed at developing and validating a random forest model of CT-PET image features combined ...
A CT-scan of lungs has become ubiquitous as a thoracic diagnostic tool. Thus, using CT-scan images i...
It remains a challenge to preoperatively forecast whether lung pure ground-glass nodules (pGGNs) hav...
Routine follow-up visits and radiographic imaging are required for outcome evaluation and tumor recu...
Background and purpose: Radiomics provides opportunities to quantify the tumor phenotype non-invasiv...
This paper concerns the development/analysis of the IQ-OTH/NCCD lung cancer dataset. This CT-scan da...
Stereotactic ablative radiotherapy (SABR) is the standard treatment recommendation for Stage I non-s...
PURPOSE:Radiomics provides quantitative tissue heterogeneity profiling and is an exciting approach t...
BACKGROUND: Lung cancer is one of the most common forms of cancer resulting in over a million deaths...
Lung cancer is one of the most common forms of cancer resulting in over a million deaths per year wo...
[[abstract]]Lung cancer is one of the major diseases which causes death in developed as well as deve...
BACKGROUND: Radiomics can quantify tumor phenotypic characteristics non-invasively by applying featu...
Lung cancer can be classified into two main categories: small cell lung cancer (SCLC) and non-small ...
Lung cancer is the leading cause of cancer-related death in the United States and worldwide. Early ...
Purpose: A new set of quantitative features that capture intensity changes in PET/CT images over tim...
The work aimed at developing and validating a random forest model of CT-PET image features combined ...
A CT-scan of lungs has become ubiquitous as a thoracic diagnostic tool. Thus, using CT-scan images i...
It remains a challenge to preoperatively forecast whether lung pure ground-glass nodules (pGGNs) hav...
Routine follow-up visits and radiographic imaging are required for outcome evaluation and tumor recu...
Background and purpose: Radiomics provides opportunities to quantify the tumor phenotype non-invasiv...
This paper concerns the development/analysis of the IQ-OTH/NCCD lung cancer dataset. This CT-scan da...
Stereotactic ablative radiotherapy (SABR) is the standard treatment recommendation for Stage I non-s...